Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	actin binding	KIF18A MYLK COBLL1 DAG1 RCSD1 SPATA31C1 MYOZ1 MACF1 EPS8L3 PLEKHH2 PALLD	7.38e-05	479	111	11	GO:0003779
GeneOntologyBiologicalProcess	neuron projection development	TANC2 NYAP2 RASGRF1 RB1 MAP4 DAG1 GOLGA6B SRCIN1 MECP2 MEF2C RNF157 TRIM67 ITSN2 MACF1 CTNND2 PALLD MOV10 GPRIN2 EPHA7	3.11e-05	1285	107	19	GO:0031175
GeneOntologyBiologicalProcess	modulation of chemical synaptic transmission	LILRA2 RASGRF1 RASGRF2 DAG1 DGKB MECP2 MEF2C DGKI CTNND2 GRIN3B BSN IGSF21 EPHA7	3.93e-05	663	107	13	GO:0050804
GeneOntologyBiologicalProcess	regulation of trans-synaptic signaling	LILRA2 RASGRF1 RASGRF2 DAG1 DGKB MECP2 MEF2C DGKI CTNND2 GRIN3B BSN IGSF21 EPHA7	3.99e-05	664	107	13	GO:0099177
GeneOntologyBiologicalProcess	neuron projection morphogenesis	TANC2 NYAP2 DAG1 GOLGA6B SRCIN1 MECP2 MEF2C RNF157 ITSN2 MACF1 CTNND2 PALLD MOV10 EPHA7	6.86e-05	802	107	14	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	TANC2 NYAP2 DAG1 GOLGA6B SRCIN1 MECP2 MEF2C RNF157 ITSN2 MACF1 CTNND2 PALLD MOV10 EPHA7	8.58e-05	819	107	14	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	TANC2 NYAP2 DAG1 GOLGA6B SRCIN1 MECP2 MEF2C RNF157 ITSN2 MACF1 CTNND2 PALLD MOV10 EPHA7	9.38e-05	826	107	14	GO:0048858
GeneOntologyBiologicalProcess	cell morphogenesis	TANC2 NYAP2 RB1 DAG1 GOLGA6B SRCIN1 MED1 MECP2 MEF2C RNF157 TBC1D20 ITSN2 MACF1 CTNND2 PALLD MOV10 EPHA7	1.36e-04	1194	107	17	GO:0000902
GeneOntologyBiologicalProcess	regulation of synaptic plasticity	LILRA2 RASGRF1 RASGRF2 DAG1 MECP2 MEF2C DGKI CTNND2	1.46e-04	293	107	8	GO:0048167
GeneOntologyBiologicalProcess	neuron development	TANC2 NYAP2 RASGRF1 RB1 MAP4 DAG1 GOLGA6B SRCIN1 MECP2 MEF2C RNF157 TRIM67 ITSN2 MACF1 CTNND2 PALLD MOV10 GPRIN2 EPHA7	1.74e-04	1463	107	19	GO:0048666
GeneOntologyCellularComponent	postsynaptic density	TANC2 MAP4 DGKB SRCIN1 DGKI MACF1 CTNND2 GRIN3B BSN IGSF21 EPHA7	2.40e-05	451	109	11	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	TANC2 MAP4 DGKB SRCIN1 DGKI MACF1 CTNND2 GRIN3B BSN IGSF21 EPHA7	4.00e-05	477	109	11	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	TANC2 MAP4 DGKB SRCIN1 DGKI MACF1 CTNND2 GRIN3B BSN IGSF21 EPHA7	6.44e-05	503	109	11	GO:0099572
GeneOntologyCellularComponent	neuron to neuron synapse	TANC2 MAP4 DGKB SRCIN1 DGKI MACF1 CTNND2 GRIN3B BSN IGSF21 EPHA7	9.11e-05	523	109	11	GO:0098984
GeneOntologyCellularComponent	glutamatergic synapse	TANC2 PRUNE2 RASGRF2 ADGRB2 DAG1 DGKB SRCIN1 MECP2 AP3M2 DGKI CTNND2 BSN EPHA7	3.31e-04	817	109	13	GO:0098978
GeneOntologyCellularComponent	supramolecular polymer	KIF18A COL10A1 MAP4 FBF1 DNAH2 DAG1 RCSD1 NCKAP5 GOLGA6B MEF2C CEP170 MYOZ1 AHNAK NAV1 MACF1 PALLD	4.28e-04	1187	109	16	GO:0099081
GeneOntologyCellularComponent	postsynapse	TANC2 MAP4 DAG1 DGKB SRCIN1 MECP2 MEF2C DGKI MACF1 CTNND2 GRIN3B BSN IGSF21 EPHA7	8.29e-04	1018	109	14	GO:0098794
GeneOntologyCellularComponent	supramolecular fiber	KIF18A MAP4 FBF1 DNAH2 DAG1 RCSD1 NCKAP5 GOLGA6B MEF2C CEP170 MYOZ1 AHNAK NAV1 MACF1 PALLD	1.18e-03	1179	109	15	GO:0099512
GeneOntologyCellularComponent	extrinsic component of postsynaptic density membrane	DGKB DGKI	1.18e-03	10	109	2	GO:0099147
Pathway	REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF	EP400 RB1 UBN1	5.56e-05	15	72	3	MM14902
Pathway	REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF	EP400 RB1 UBN1	8.25e-05	17	72	3	M27189
Pathway	WP_RETT_SYNDROME	MECP2 MEF2C NCOR1 SMARCA1	1.03e-04	48	72	4	M39759
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TANC2 PRUNE2 ATP8B4 COBLL1 CEP350 CEP170 VPS13D AHRR MACF1 PLEKHH2 MGA REXO1L1P PALLD MOV10	8.40e-10	493	113	14	15368895
Pubmed	Human transcription factor protein interaction networks.	TRAF3 ESS2 EP400 RB1 ARID4A ATXN7L1 MSANTD2 ID4 NUP214 MEF2C ZFPM2 NCOR1 FOXP4 UBN1 GTF3C2 MKI67 SMARCA1 ZFHX3 MGA SMAP2 MOV10	6.33e-09	1429	113	21	35140242
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	KIF18A COL10A1 ESS2 LRCH2 SRCIN1 MECP2 MEF2C CEP350 THAP4 NCOR1 UBN1 SULT1C2 DGKI PLEKHH2 MGA	7.36e-09	689	113	15	36543142
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP4 CEP350 CEP170 NCOR1 UBN1 MKI67 NAV1 MGA PALLD	9.93e-09	184	113	9	32908313
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TANC2 TRAF3 NYAP2 LRCH2 ADGRB2 MSANTD2 GOLGA6B CEP170 NCOR1 TDRD3 TRIM67 NAV1 DGKI MACF1 CTNND2 BSN MGA	1.51e-08	963	113	17	28671696
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	KIF18A ESS2 EP400 MAP4 MED1 CEP170 NCOR1 UBN1 MAVS AHNAK MGA PALLD	2.50e-08	444	113	12	34795231
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	KIF18A ESS2 EP400 RB1 ARID4A NSD2 MED1 MECP2 CEP350 CEP170 UBN1 GTF3C2 AHNAK NAV1	2.51e-08	645	113	14	25281560
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 MAP4 COBLL1 DTL C6orf132 CEP350 CEP170 VPS13D AHNAK NAV2 NAV1 MACF1 BOD1L1 SMAP2 PALLD	1.36e-07	861	113	15	36931259
Pubmed	Interaction network of human early embryonic transcription factors.	EP400 ARID4A DTL NUP214 NCOR1 FOXP4 MKI67 SMARCA1 ZFHX3 MGA	2.39e-07	351	113	10	38297188
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	EP400 MAP4 MED1 MECP2 NCOR1 MKI67 ZFHX3 BOD1L1 MGA	3.93e-07	283	113	9	30585729
Pubmed	A human MAP kinase interactome.	COBLL1 NCKAP5 NUP214 MEF2C CEP350 ITSN2 NAV2 NAV1 MACF1 CPLANE1 MGA	5.73e-07	486	113	11	20936779
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	TANC2 NYAP2 SRCIN1 TDRD3 TRIM67 AP3M2 CTNND2 BSN	6.10e-07	218	113	8	33378226
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ESS2 RB1 ARID4A NSD2 MED1 MECP2 UBN1 GTF3C2 MKI67 SMARCA1 BOD1L1 MGA	7.27e-07	608	113	12	36089195
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ZCWPW1 ESS2 EP400 RB1 ARID4A ID4 MECP2 MEF2C NCOR1 FOXP4 GTF3C2 SMARCA1 MGA MOV10	7.87e-07	857	113	14	25609649
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ATXN7L1 AHRR MAVS ITSN2 NAV1 MACF1	1.14e-06	103	113	6	10574462
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	PRUNE2 ESS2 EP400 NUP214 C6orf132 NCOR1 UBN1 AFF1 BSN MGA	1.50e-06	430	113	10	35044719
Pubmed	Laser capture microdissection and cDNA array analysis for identification of mouse KIAA/FLJ genes differentially expressed in the embryonic dorsal spinal cord.	NUP214 RNF157 NAV2 MACF1	1.75e-06	27	113	4	19026994
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	EP400 MAP4 ARID4A NSD2 NUP214 MED1 MECP2 CEP170 NCOR1 UBN1 AHNAK MKI67 BOD1L1 MGA	2.75e-06	954	113	14	36373674
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	RASGRF1 MAP4 FBF1 CEP170 ADAMTS18 MACF1 CTNND2 CPLANE1 PALLD	2.93e-06	361	113	9	26167880
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 EP400 NSD2 ADGRB2 NUP214 ZNF236 C6orf132 NCOR1 TDRD3 UBN1 AHNAK NAV2 NAV1 SLC45A1 CRAMP1	3.05e-06	1105	113	15	35748872
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	EP400 NUP214 MECP2 ZFPM2 GTF3C2 AHNAK SMARCA1 KIAA1958 BOD1L1 MOV10	3.25e-06	469	113	10	27634302
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	AMBN TANC2 EP400 RB1 ATXN7L1 NSD2 FBF1 MECP2 CEP170 FOXP4 TC2N SMARCA1 MACF1 ZFHX3 MGA	3.44e-06	1116	113	15	31753913
Pubmed	Transcription factor epiprofin is essential for tooth morphogenesis by regulating epithelial cell fate and tooth number.	AMBN RB1 MKI67	3.94e-06	10	113	3	18156176
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYLK NSD2 FBF1 DTL DNAH2 GOLGA6B MECP2 NCOR1 TRIM67 AHNAK ITSN2 SMARCA1 NAV2 MACF1 BOD1L1 DLEC1 BSN	4.21e-06	1442	113	17	35575683
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MAP4 MED1 CEP350 CEP170 TDRD3 AHNAK MKI67 MACF1 MGA SMAP2 PALLD MOV10	4.40e-06	724	113	12	36232890
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	EP400 ATXN7L1 VPS13D ITSN2 NAV1 MACF1	4.42e-06	130	113	6	12421765
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	MAP4 COBLL1 DTL MED1 NCOR1 GTF3C2 MAVS MKI67 NAV2 PALLD	6.02e-06	503	113	10	16964243
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	LRCH2 EP400 DGKB NUP214 RNF157 ITSN2 NAV1 MACF1 BOD1L1	7.70e-06	407	113	9	12693553
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	TANC2 NYAP2 VTN FBF1 DNAH2 MED1 CEP350 NCOR1 ITSN2 CTNND2 BSN	7.79e-06	638	113	11	31182584
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	KIF18A ESS2 EP400 ATXN7L1 UBN1 MGA SPTY2D1	8.55e-06	222	113	7	37071664
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NYAP2 EP400 NSD2 FBF1 SNRK SRCIN1 GTF3C2 NAV2 BSN CRAMP1	9.32e-06	529	113	10	14621295
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	MSANTD2 NUP214 NCOR1 GTF3C2 AHNAK NAV1 KIAA1958 ZFHX3 MGA	9.53e-06	418	113	9	34709266
Pubmed	RASGRF2 controls nuclear migration in postnatal retinal cone photoreceptors.	RASGRF1 RASGRF2	1.05e-05	2	113	2	26743081
Pubmed	Distinct roles for Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and Ras-GRF2 in the induction of long-term potentiation and long-term depression.	RASGRF1 RASGRF2	1.05e-05	2	113	2	16467520
Pubmed	The environment versus genetics in controlling the contribution of MAP kinases to synaptic plasticity.	RASGRF1 RASGRF2	1.05e-05	2	113	2	17141611
Pubmed	Transgenerational rescue of a genetic defect in long-term potentiation and memory formation by juvenile enrichment.	RASGRF1 RASGRF2	1.05e-05	2	113	2	19193896
Pubmed	Rb silencing mediated by the down-regulation of MeCP2 is involved in cell transformation induced by long-term exposure to hydroquinone.	RB1 MECP2	1.05e-05	2	113	2	27377594
Pubmed	Activation of H-Ras in the endoplasmic reticulum by the RasGRF family guanine nucleotide exchange factors.	RASGRF1 RASGRF2	1.05e-05	2	113	2	14749369
Pubmed	Giant scaffolding protein AHNAK1 interacts with β-dystroglycan and controls motility and mechanical properties of Schwann cells.	DAG1 AHNAK	1.05e-05	2	113	2	24796807
Pubmed	Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.	PFKFB3 MKI67	1.05e-05	2	113	2	29327288
Pubmed	Influenza a virus NS1 resembles a TRAF3-interacting motif to target the RNA sensing-TRAF3-type I IFN axis and impair antiviral innate immunity.	TRAF3 MAVS	1.05e-05	2	113	2	34610835
Pubmed	A murine CDC25/ras-GRF-related protein implicated in Ras regulation.	RASGRF1 RASGRF2	1.05e-05	2	113	2	8293576
Pubmed	Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif.	TRAF3 MAVS	1.05e-05	2	113	2	16858409
Pubmed	Interaction Between Susceptibility Loci in MAVS and TRAF3 Genes, and High-risk HPV Infection on the Risk of Cervical Precancerous Lesions in Chinese Population.	TRAF3 MAVS	1.05e-05	2	113	2	30463990
Pubmed	Whole-exome sequence analysis highlights the role of unmasked recessive mutations in copy number variants with incomplete penetrance.	NUP214 NCOR1	1.05e-05	2	113	2	29483668
Pubmed	Ras-GRF2 regulates nestin-positive stem cell density and onset of differentiation during adult neurogenesis in the mouse dentate gyrus.	RASGRF1 RASGRF2	1.05e-05	2	113	2	28966131
Pubmed	The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice.	RASGRF1 RASGRF2	1.05e-05	2	113	2	31182637
Pubmed	Setd5 is essential for mammalian development and the co-transcriptional regulation of histone acetylation.	MEF2C NCOR1 MKI67	1.18e-05	14	113	3	27864380
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	EP400 MAP4 MED1 CEP170 NCOR1 GTF3C2 AHNAK BOD1L1 MGA PALLD	1.28e-05	549	113	10	38280479
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	EP400 MAP4 NUP214 NCOR1 GTF3C2 AHNAK BOD1L1 PALLD	1.36e-05	332	113	8	32786267
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	MAP4 COBLL1 DAG1 SRCIN1 NUP214 C6orf132 MAVS AHNAK NAV2 MACF1	1.64e-05	565	113	10	25468996
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	TANC2 RASGRF1 MAP4 SRCIN1 MECP2 MACF1 CTNND2 BSN	1.87e-05	347	113	8	17114649
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	EP400 ARID4A NSD2 NUP214 MED1 MECP2 THAP4 NCOR1 UBN1 GTF3C2 AHNAK MKI67 MGA TAPBP SPTY2D1	1.99e-05	1294	113	15	30804502
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ESS2 EP400 RB1 DTL NCOR1 TDRD3 UBN1 NAV1 MACF1 BSN	2.31e-05	588	113	10	38580884
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PRUNE2 MAP4 ATXN7L1 NSD2 SRCIN1 ZNF236 CEP170 THAP4 FOXP4 NAV1 AFF1 MACF1 ZFHX3 BOD1L1 GREB1 CRAMP1	2.59e-05	1489	113	16	28611215
Pubmed	Proteomic analysis of in vivo phosphorylated synaptic proteins.	MAP4 SRCIN1 CTNND2 BSN	2.74e-05	53	113	4	15572359
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ESS2 EP400 DTL NUP214 CEP350 CEP170 TDRD3 MAVS NAV1 BOD1L1 MGA	2.81e-05	733	113	11	34672954
Pubmed	Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions.	ESS2 MEF2C NCOR1 TC2N MAVS	3.09e-05	110	113	5	37219487
Pubmed	Single-cell atlas of early human brain development highlights heterogeneity of human neuroepithelial cells and early radial glia.	ID4 MEF2C MKI67	3.12e-05	19	113	3	33723434
Pubmed	MAVS Promotes Inflammasome Activation by Targeting ASC for K63-Linked Ubiquitination via the E3 Ligase TRAF3.	TRAF3 MAVS	3.13e-05	3	113	2	25847972
Pubmed	Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ.	MED1 NCOR1	3.13e-05	3	113	2	30575522
Pubmed	Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers.	TRAF3 RB1	3.13e-05	3	113	2	29921694
Pubmed	RBP1 induces growth arrest by repression of E2F-dependent transcription.	RB1 ARID4A	3.13e-05	3	113	2	10321733
Pubmed	RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation.	RASGRF1 RASGRF2	3.13e-05	3	113	2	21685891
Pubmed	KMT2D deficiency disturbs the proliferation and cell cycle activity of dental epithelial cell line (LS8) partially via Wnt signaling.	RB1 MKI67	3.13e-05	3	113	2	34724040
Pubmed	MMSET is dynamically regulated during cell-cycle progression and promotes normal DNA replication.	NSD2 DTL	3.13e-05	3	113	2	26771714
Pubmed	MiR-218 affects hypertrophic differentiation of human mesenchymal stromal cells during chondrogenesis via targeting RUNX2, MEF2C, and COL10A1.	COL10A1 MEF2C	3.13e-05	3	113	2	33303006
Pubmed	Meckel's and condylar cartilages anomalies in achondroplasia result in defective development and growth of the mandible.	COL10A1 MKI67	3.13e-05	3	113	2	27260401
Pubmed	Mef2 promotes spine elimination in absence of δ-catenin.	MEF2C CTNND2	3.13e-05	3	113	2	23328440
Pubmed	HACE1 Negatively Regulates Virus-Triggered Type I IFN Signaling by Impeding the Formation of the MAVS-TRAF3 Complex.	TRAF3 MAVS	3.13e-05	3	113	2	27213432
Pubmed	Targeted disruption of Ras-Grf2 shows its dispensability for mouse growth and development.	RASGRF1 RASGRF2	3.13e-05	3	113	2	11909944
Pubmed	Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex.	TRAF3 MAVS	3.13e-05	3	113	2	22901541
Pubmed	Gene-specific universal mammalian sequence-tagged sites: application to the canine genome.	COL10A1 RB1	3.13e-05	3	113	2	8894053
Pubmed	Biomarkers distinguishing mammary fibroepithelial neoplasms: a tissue microarray study.	RB1 MKI67	3.13e-05	3	113	2	25003838
Pubmed	MeCP2-dependent repression of an imprinted miR-184 released by depolarization.	RASGRF1 MECP2	3.13e-05	3	113	2	18203756
Pubmed	Expression of pRb, Ki67 and HER 2/neu in gastric carcinomas: Relation to different histopathological grades and stages.	RB1 MKI67	3.13e-05	3	113	2	28965621
Pubmed	Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB.	RASGRF1 RASGRF2	3.13e-05	3	113	2	15029245
Pubmed	Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product.	RB1 ARID4A	3.13e-05	3	113	2	1857421
Pubmed	Neuron navigator: a human gene family with homology to unc-53, a cell guidance gene from Caenorhabditis elegans.	NAV2 NAV1	3.13e-05	3	113	2	12079279
Pubmed	Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53.	NAV2 NAV1	3.13e-05	3	113	2	15158073
Pubmed	pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation.	RB1 MEF2C	3.13e-05	3	113	2	10322110
Pubmed	Pore membrane and/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms.	NAV2 NAV1	3.13e-05	3	113	2	12062803
Pubmed	Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation.	MECP2 MEF2C	3.13e-05	3	113	2	34183865
Pubmed	The DNA sequence and biological annotation of human chromosome 1.	DTL ADGRB2 CEP350 CEP170 VPS13D TRIM67 MACF1 EPS8L3 SLC45A1 ZP4 IGSF21 SMAP2 MOV10	3.15e-05	1031	113	13	16710414
Pubmed	Characterization of cDNA clones in size-fractionated cDNA libraries from human brain.	CEP350 CEP170 VPS13D MACF1	3.41e-05	56	113	4	9455484
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	KIF18A MAP4 NSD2 MED1 CEP170 TDRD3 GTF3C2 MKI67 MACF1 SPTY2D1 MOV10	3.85e-05	759	113	11	35915203
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	EP400 MAP4 ARID4A NUP214 MED1 MECP2 NCOR1 UBN1 MKI67 KIAA1958 AFF1	4.59e-05	774	113	11	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	EP400 CEP350 NCOR1 MAVS AHNAK MKI67 ZFHX3 MGA SMAP2 SPTY2D1 PLEKHA8	4.75e-05	777	113	11	35844135
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EP400 MAP4 NUP214 MED1 CEP170 TDRD3 MAVS AHNAK MKI67 MACF1 BOD1L1 PALLD	5.41e-05	934	113	12	33916271
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	MSANTD2 FOXP4 GTF3C2 KIAA1958 MGA	5.70e-05	125	113	5	32891193
Pubmed	A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response.	TRAF3 MAVS	6.25e-05	4	113	2	21200404
Pubmed	Nephronectin plays critical roles in Sox2 expression and proliferation in dental epithelial stem cells via EGF-like repeat domains.	AMBN MKI67	6.25e-05	4	113	2	28345658
Pubmed	ARID4A and ARID4B regulate male fertility, a functional link to the AR and RB pathways.	RB1 ARID4A	6.25e-05	4	113	2	23487765
Pubmed	Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1.	RB1 MECP2	6.25e-05	4	113	2	12473678
Pubmed	UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS.	TRAF3 MAVS	6.25e-05	4	113	2	23545497
Pubmed	Deficiency of Rbbp1/Arid4a and Rbbp1l1/Arid4b alters epigenetic modifications and suppresses an imprinting defect in the PWS/AS domain.	RB1 ARID4A	6.25e-05	4	113	2	17043311
Pubmed	Upper aerodigestive tract squamous dysplasia: correlation with p16, p53, pRb, and Ki-67 expression.	RB1 MKI67	6.25e-05	4	113	2	16948516
Pubmed	Structural and spatial determinants regulating TC21 activation by RasGRF family nucleotide exchange factors.	RASGRF1 RASGRF2	6.25e-05	4	113	2	19692568
Pubmed	Differential expression of cyclin D1, Ki‑67, pRb, and p53 in psoriatic skin lesions and normal skin.	RB1 MKI67	6.25e-05	4	113	2	29115643
Pubmed	Involvement of apoptotic cell death and cell cycle perturbation in retinoic acid-induced cleft palate in mice.	RB1 MKI67	6.25e-05	4	113	2	17442359
Interaction	NRXN1 interactions	MAP4 DAG1 SRCIN1 MECP2 CEP170 MACF1 CTNND2 BSN	5.11e-07	127	111	8	int:NRXN1
Interaction	MAPRE3 interactions	MAP4 NCKAP5 C6orf132 CEP350 CEP170 TDRD3 TRIM67 NAV2 NAV1 MACF1	5.81e-07	230	111	10	int:MAPRE3
Interaction	PRNP interactions	KIF18A COL10A1 ESS2 MYLK LRCH2 MAP4 DAG1 SRCIN1 MECP2 MEF2C CEP350 THAP4 NCOR1 TRIM67 UBN1 SULT1C2 DGKI MACF1 PLEKHH2 BSN MGA	1.20e-06	1158	111	21	int:PRNP
Interaction	CBX3 interactions	ESS2 EP400 RB1 NSD2 COBLL1 MSANTD2 SNRK MED1 MECP2 NCOR1 TRIM67 MKI67 SMARCA1 MACF1 MGA	2.60e-06	646	111	15	int:CBX3
Interaction	BAG2 interactions	ESS2 DNAH2 CEP170 NCOR1 TDRD3 VPS13D TRIM67 GTF3C2 MAVS AHNAK BOD1L1 GREB1 SMAP2 PALLD	8.22e-06	622	111	14	int:BAG2
Interaction	NUP43 interactions	EP400 MAP4 ARID4A NSD2 NUP214 MECP2 NCOR1 TRIM67 MAVS MKI67 SMARCA1 ZFHX3 BOD1L1 MGA	8.68e-06	625	111	14	int:NUP43
Interaction	SNRNP40 interactions	ESS2 EP400 NSD2 MECP2 NCOR1 TRIM67 UBN1 ITSN2 MKI67 SMARCA1 ZFHX3 MGA SPTY2D1 MOV10	1.07e-05	637	111	14	int:SNRNP40
Interaction	YWHAH interactions	TANC2 LRCH2 COBLL1 DTL PFKFB3 MED1 C6orf132 CEP350 CEP170 VPS13D TRIM67 AHNAK NAV2 NAV1 MACF1 BOD1L1 SMAP2 PALLD	3.16e-05	1102	111	18	int:YWHAH
Interaction	H3C1 interactions	NSD2 COBLL1 DNAH2 MECP2 NCOR1 TRIM67 UBN1 GTF3C2 AHNAK MKI67 SMARCA1 NAV2 ZFHX3 MGA PALLD MOV10	3.39e-05	901	111	16	int:H3C1
Interaction	CORO2A interactions	RB1 RGS3 THAP4 NCOR1 TRIM67	3.66e-05	68	111	5	int:CORO2A
Interaction	BNC2 interactions	BNC2 RB1 FOXP4	4.47e-05	13	111	3	int:BNC2
Interaction	TNIK interactions	TANC2 MSANTD2 CEP170 TDRD3 TRIM67 DGKI MACF1 CTNND2 MGA EPHA7	4.91e-05	381	111	10	int:TNIK
Interaction	TERF2IP interactions	ESS2 EP400 RB1 NSD2 MED1 NCOR1 TRIM67 MKI67 SMARCA1 BOD1L1 MGA RABIF	5.31e-05	552	111	12	int:TERF2IP
Interaction	CCNB1 interactions	RB1 MAP4 ARID4A FBF1 MEF2C CEP170 TRIM67 NAV1	6.22e-05	244	111	8	int:CCNB1
Interaction	LHX2 interactions	EP400 MECP2 NCOR1 FOXP4 SMARCA1 ZFHX3 MGA	6.96e-05	183	111	7	int:LHX2
Interaction	UNC13A interactions	MECP2 BSN MOV10	8.64e-05	16	111	3	int:UNC13A
Interaction	H3C3 interactions	ESS2 RB1 ARID4A NSD2 MED1 MECP2 GTF3C2 MKI67 SMARCA1 BOD1L1 MGA	9.11e-05	495	111	11	int:H3C3
Interaction	MYOD1 interactions	EP400 RB1 MSANTD2 ID4 MEF2C NCOR1 MGA	1.00e-04	194	111	7	int:MYOD1
Interaction	SFN interactions	TANC2 MAP4 COBLL1 DTL C6orf132 CEP350 CEP170 TRIM67 NAV2 NAV1 MACF1 PALLD GPRIN2	1.12e-04	692	111	13	int:SFN
Interaction	PPP1CA interactions	TANC2 KIF18A TRAF3 VTN RB1 MAP4 MECP2 CEP170 NCOR1 TRIM67 LPIN2 MKI67 SLC45A1	1.19e-04	696	111	13	int:PPP1CA
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	EP400 MSANTD2 NCOR1 SMARCA1 CRAMP1	2.82e-06	53	76	5	532
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKB DGKI	7.68e-04	10	76	2	1178
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	TRAF3 BSN	1.77e-03	15	76	2	26
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RASGRF1 RASGRF2 ITSN2	2.70e-03	66	76	3	722
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	ESS2 LRCH2 NSD2 AHNAK	1.37e-05	34	113	4	M11023
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	ESS2 LRCH2 NSD2 AHNAK	1.73e-05	36	113	4	MM486
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000	TANC2 KIF18A BNC2 MYLK NUP214 PFKFB3 MEF2C RNF157 ZFPM2 CEP350 CEP170 NCOR1 ERCC6L2 SMARCA1 CPLANE1 EPHA7	3.82e-06	811	109	16	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000	BNC2 ZFPM2 AHNAK SMARCA1 PLEKHH2 EPHA7	1.08e-05	97	109	6	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000	BNC2 ARID4A NCKAP5 MEF2C RNF157 CEP170 NCOR1 SMARCA1 SPTY2D1 EPHA7	1.28e-05	349	109	10	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	KIF18A TRAF3 RB1 ARID4A DGKB ID4 NCKAP5 MECP2 NCOR1 TDRD3 MKI67 ERCC6L2 BOD1L1 CTNND2 TAPBP	2.25e-05	831	109	15	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_200	BNC2 ZFPM2 PALLD EPHA7	3.81e-05	37	109	4	gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_200
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000	KIF18A RASGRF2 NSD2 COBLL1 ID4 NUP214 C6orf132 CEP350 ERCC6L2 ADAMTS18 GREB1 CTNND2 CPLANE1 SPTY2D1	6.11e-05	801	109	14	gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_1000	PFKFB3 RNF157 CEP170 NCOR1 SMARCA1 EPHA7	7.90e-05	138	109	6	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000	BNC2 MYLK ARID4A NCKAP5 MEF2C RNF157 ZFPM2 CEP170 NCOR1 ERCC6L2 SMARCA1 CPLANE1 SPTY2D1 EPHA7	8.47e-05	826	109	14	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500	NUP214 CEP350 ERCC6L2 KIAA1958 CPLANE1 EPHA7	1.21e-04	149	109	6	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	BNC2 ZCWPW1 MYLK SHBG NCKAP5 MEF2C ZFPM2 CEP350 SMARCA1 NAV1 PLEKHH2 PALLD EPHA7	1.67e-04	773	109	13	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	COBLL1 SHBG DAG1 MEF2C ZFPM2 FOXP4 LPIN2 SMARCA1 NAV2 NAV1 TLE6 AFF1 MOV10 EPHA7	1.72e-04	884	109	14	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	TRAF3 MAP4 ARID4A MECP2 TDRD3 MAVS ITSN2 MKI67 ERCC6L2 SMARCA1 MACF1 CPLANE1 TAPBP	1.82e-04	780	109	13	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_200	KIF18A MYLK ID4 ERCC6L2 CPLANE1 EPHA7	2.04e-04	164	109	6	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000	BNC2 LRCH2 ADGRB2 MED1 MECP2 ZFPM2 CEP170 NCOR1 TDRD3 SMARCA1 ADAMTS18 ZFHX3 MGA	2.09e-04	791	109	13	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	TANC2 BNC2 SHBG DAG1 ZFPM2 TDRD3 AHNAK SMARCA1 NAV2 AFF1 PLEKHH2 MOV10 EPHA7	2.09e-04	791	109	13	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	TANC2 BNC2 ARID4A NCKAP5 MECP2 CEP170 NCOR1 TDRD3 ZFHX3 SPTY2D1	2.24e-04	492	109	10	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	BNC2 MAP4 NSD2 MSANTD2 DAG1 RNF157 NAV2 ADAMTS18 ZFHX3 GREB1 CPLANE1 MGA EPHA7	2.45e-04	804	109	13	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_500	BNC2 ZFPM2 SMARCA1 EPHA7	2.74e-04	61	109	4	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k3_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	TANC2 BNC2 MAP4 DGKB ID4 RNF157 CEP350 CEP170 ERCC6L2 ADAMTS18 CTNND2 CPLANE1 EPHA7	2.89e-04	818	109	13	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	BNC2 ZCWPW1 DTL SHBG RNF157 ZFPM2 CEP350 TDRD3 SMARCA1 AFF1 PLEKHH2 PALLD EPHA7	3.21e-04	827	109	13	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500	BNC2 MYLK MEF2C RNF157 ZFPM2 CEP170 NCOR1 ERCC6L2 EPHA7	3.28e-04	422	109	9	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	KIF18A RASGRF2 ID4 NUP214 CEP350 ERCC6L2 CPLANE1 SPTY2D1	3.65e-04	339	109	8	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500	COBLL1 SHBG DAG1 MEF2C ZFPM2 SMARCA1 NAV1 MOV10 EPHA7	3.96e-04	433	109	9	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_500
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_200	ZFPM2 SMARCA1 EPHA7	5.33e-04	31	109	3	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k3_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	TANC2 BNC2 ZFPM2 SMARCA1 PLEKHH2 EPHA7	5.72e-04	199	109	6	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	COBLL1 SHBG DAG1 MEF2C ZFPM2 FOXP4 SMARCA1 NAV2 NAV1 AFF1 TAPBP MOV10 EPHA7	5.77e-04	880	109	13	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_100	ZFPM2 SMARCA1 EPHA7	5.86e-04	32	109	3	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	KIF18A NUP214 MECP2 C6orf132 CEP350 CEP170 ERCC6L2 ADAMTS18 ZFHX3 CTNND2 CPLANE1 EPHA7	5.88e-04	769	109	12	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_500	BNC2 RNF157 CEP170 NCOR1 EPHA7	5.99e-04	132	109	5	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_500
ToppCell	367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	ATP8B4 RB1 RCSD1 NCKAP5 PFKFB3 MEF2C NAV2 IGSF21 SMAP2	1.90e-09	196	113	9	e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 MYLK MAP4 DGKB SLC45A1 PLEKHH2 IGSF21 PALLD EPHA7	2.08e-09	198	113	9	cbb63b255bdc92a557c5db1f08f7766ed9346607
ToppCell	Sepsis-URO-Lymphocyte-T/NK-dn_T\|URO / Disease, condition lineage and cell class	KIF18A MSANTD2 SNRK ANKRD36C TBC1D20 THAP4 PIGO RABIF MOV10	2.27e-09	200	113	9	04ea6381b93a5d8bbeda4d71c788d7fbac6d40bc
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL10A1 MYLK LRCH2 ZFPM2 NAV2 MACF1 PLEKHH2 PALLD	1.61e-08	175	113	8	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	VTN MYLK COBLL1 RCSD1 AHNAK ZFHX3 PALLD	2.10e-07	164	113	7	9eed945e9b0c1ee5fc62724ac2bbbed4267b0678
ToppCell	primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	VTN MYLK COBLL1 RCSD1 AHNAK ZFHX3 PALLD	2.10e-07	164	113	7	f510f20e37e31b486cdd0e3f597ce4ff00877c5d
ToppCell	primary_visual_cortex-Non-neuronal-smooth_muscle_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	VTN MYLK COBLL1 RCSD1 AHNAK ZFHX3 PALLD	2.10e-07	164	113	7	5c932a462cbf81d029c8d11ec3aea3191529527b
ToppCell	URO-Lymphocyte-T_NK-dnT\|URO / Disease, Lineage and Cell Type	KIF18A MSANTD2 SNRK ANKRD36C TBC1D20 PIGO RABIF	4.25e-07	182	113	7	f2b1c524301d0f2d1b69c46f3653fd53c21c3aa0
ToppCell	Control-immature_Neutrophil-\|Control / Disease condition and Cell class	TANC2 KIF18A ATP8B4 NSD2 ANKRD36C RGS3 MKI67	4.57e-07	184	113	7	c4e8ba82a6aa76c46f05a71d5f1c7926555318cf
ToppCell	Control-immature_Neutrophil\|Control / Disease condition and Cell class	TANC2 KIF18A ATP8B4 NSD2 ANKRD36C RGS3 MKI67	4.57e-07	184	113	7	2fdae5c6b3eb2232881d933a8c1061fda3623016
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	MYLK ARID4A MED1 CEP350 VPS13D BOD1L1 SPTY2D1	4.92e-07	186	113	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	BNC2 MYLK ZFPM2 NAV2 MACF1 PLEKHH2 PALLD	5.10e-07	187	113	7	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 BNC2 MYLK ID4 ZFPM2 ZFHX3 PALLD	5.48e-07	189	113	7	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 BNC2 ADGRB2 DGKB ID4 PALLD EPHA7	5.48e-07	189	113	7	4dc32b463546bbe7250dddd281b92ad17ec22da1
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 BNC2 ADGRB2 DGKB ID4 PALLD EPHA7	5.48e-07	189	113	7	0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC2 MYLK ZFPM2 NAV2 MACF1 PLEKHH2 PALLD	5.88e-07	191	113	7	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC2 MYLK ZFPM2 NAV2 MACF1 PLEKHH2 PALLD	6.09e-07	192	113	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VTN MYLK DGKB ID4 TRIM67 GREB1 PALLD	6.09e-07	192	113	7	2cc712186e37fb21a964c032765c36a8b4a852cf
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	COL10A1 MYLK RGS3 NAV2 MACF1 PLEKHH2 PALLD	6.09e-07	192	113	7	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	DAG1 MED1 CEP350 AFF1 CPLANE1 MGA SPTY2D1	6.31e-07	193	113	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DTL SNRK NCKAP5 MEF2C ZFPM2 MACF1 CTNND2	6.53e-07	194	113	7	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC2 MYLK ZFPM2 NAV2 MACF1 PLEKHH2 PALLD	6.99e-07	196	113	7	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	TANC2 BNC2 MYLK RASGRF2 MACF1 PLEKHH2 PALLD	7.24e-07	197	113	7	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC2 MYLK ZFPM2 NAV2 MACF1 PLEKHH2 PALLD	7.49e-07	198	113	7	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYLK MAP4 SNRK RCSD1 SULT1C2 AHNAK MACF1	8.01e-07	200	113	7	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 MYLK ID4 ZFPM2 CPLANE1 PALLD EPHA7	8.01e-07	200	113	7	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK LRCH2 DGKB MEF2C ZFHX3 PALLD	2.53e-06	152	113	6	0cb5f4dfae04e3f4eba502bbf229007d5fa3884d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK LRCH2 DGKB MEF2C ZFHX3 PALLD	2.53e-06	152	113	6	ba89ffb5a8bb33c188f854f54b39123b6d73496a
ToppCell	frontal_cortex-Non-neuronal-smooth_muscle_cell\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYLK COBLL1 RCSD1 AHNAK ZFHX3 PALLD	3.16e-06	158	113	6	08806240228c5b780f5aef92ce2c278ae4d797cc
ToppCell	frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYLK COBLL1 RCSD1 AHNAK ZFHX3 PALLD	3.16e-06	158	113	6	496b6988f7b3439968351840ae22f56ffa1643f1
ToppCell	frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYLK COBLL1 RCSD1 AHNAK ZFHX3 PALLD	3.16e-06	158	113	6	5b3d30f92b619f14a7b48502170000fa5783358a
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 MYLK MSANTD2 SULT1C2 PLEKHH2 EPHA7	3.28e-06	159	113	6	7cda111bb98f1241989e49d490bdf51a712ea589
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium\|TCGA-Endometrium / Sample_Type by Project: Shred V9	PRUNE2 BNC2 MYLK DGKB MEF2C ZFPM2	4.82e-06	170	113	6	cdc19013da7c41d1ed8400a6a643e4c684ff9912
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal\|TCGA-Endometrium / Sample_Type by Project: Shred V9	PRUNE2 BNC2 MYLK DGKB MEF2C ZFPM2	4.82e-06	170	113	6	0bde0a40440c7fdf7ba89cac8831d4014e7a4807
ToppCell	TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue\|TCGA-Endometrium / Sample_Type by Project: Shred V9	PRUNE2 BNC2 MYLK DGKB MEF2C ZFPM2	4.82e-06	170	113	6	516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZCWPW1 DGKB RCSD1 RNF157 MKI67 ZFHX3	5.69e-06	175	113	6	3e56695a9db97cb1d3503425c48eb79bbf99213e
ToppCell	Dendritic_Cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	LILRA2 ATP8B4 RCSD1 MEF2C EPS8L3 IGSF21	6.27e-06	178	113	6	61ce3ec64c4cffceac08412e20c26e9c90ab8197
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRUNE2 BNC2 SLC17A3 NCKAP5 SULT1C2 EPHA7	6.68e-06	180	113	6	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	COVID-19-kidney-tDL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRUNE2 BNC2 SLC17A3 NCKAP5 SULT1C2 EPHA7	6.68e-06	180	113	6	864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	PRUNE2 MYLK DGKB ZFPM2 ZFHX3 PALLD	6.68e-06	180	113	6	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK SRCIN1 FOXP4 AHNAK MACF1 PALLD	6.90e-06	181	113	6	beb2771820956be8b190c0088ae3c4efdb53c897
ToppCell	facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN MYLK COBLL1 DGKB MEF2C PALLD	7.35e-06	183	113	6	8d45dff06a199b1369576657f7f9dc0249c5f841
ToppCell	facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN MYLK COBLL1 DGKB MEF2C PALLD	7.35e-06	183	113	6	421265fa15d5a028cb567bb0904e670473ef102b
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN MYLK DGKB RCSD1 ZFHX3 PALLD	7.58e-06	184	113	6	89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEF2C CEP350 NCOR1 AHNAK ITSN2 MACF1	7.58e-06	184	113	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN MYLK DGKB RCSD1 ZFHX3 PALLD	7.58e-06	184	113	6	34c84ac9a32eaf96f45b79485119cad65905817d
ToppCell	COPD-Lymphoid-B\|COPD / Disease state, Lineage and Cell class	TRAF3 COBLL1 RCSD1 MEF2C ITSN2 SMAP2	7.82e-06	185	113	6	925e79c35c381dd44ec5fb921dca09ce43140135
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 BNC2 MYLK ID4 ZFPM2 PALLD	7.82e-06	185	113	6	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 BNC2 MYLK ID4 ZFPM2 PALLD	8.06e-06	186	113	6	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	PRUNE2 BNC2 MYLK DGKB ID4 PALLD	8.31e-06	187	113	6	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATP8B4 DTL RCSD1 MKI67 TGM7 IGSF21	8.31e-06	187	113	6	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	COVID-19-kidney-Stressed_PCT\|kidney / Disease (COVID-19 only), tissue and cell type	PRUNE2 BNC2 ATP8B4 SLC17A3 NCKAP5 EPHA7	8.31e-06	187	113	6	acd305475f3609800af0d7bc68d83ef41228080b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 BNC2 MYLK ID4 ZFPM2 PALLD	8.57e-06	188	113	6	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 BNC2 MYLK ID4 ZFPM2 PALLD	8.57e-06	188	113	6	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN MYLK COBLL1 NCKAP5 SMARCA1 ZFHX3	8.83e-06	189	113	6	de51fbd6fdb24fc4549393cf41a020005444b2aa
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK MAP4 SNRK AHNAK NAV1 MACF1	9.10e-06	190	113	6	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DTL SNRK RCSD1 MEF2C TBC1D20 CTNND2	9.10e-06	190	113	6	a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DTL RCSD1 NCKAP5 MEF2C TBC1D20 CTNND2	9.10e-06	190	113	6	106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 MYLK ID4 ZFPM2 ZFHX3 PALLD	9.38e-06	191	113	6	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TANC2 SRCIN1 ADAMTS18 DGKI ZFHX3 IGSF21	9.38e-06	191	113	6	54f07e4de61735051498846afb44b1798bed8144
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 BNC2 ID4 ZFPM2 NAV2 PALLD	9.38e-06	191	113	6	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC2 COL10A1 MYLK RASGRF2 ZFPM2 PALLD	9.66e-06	192	113	6	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 MYLK ID4 ZFPM2 ZFHX3 PALLD	9.66e-06	192	113	6	992d08092edbc68c47b945deb8708379738c239a
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NSD2 RCSD1 CEP350 MACF1 ZFHX3 BOD1L1	9.66e-06	192	113	6	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN MYLK COBLL1 DGKB SMARCA1 PALLD	9.95e-06	193	113	6	1043b28503bfaa0d5a82ec358bc86cbde73ea8f2
ToppCell	MNPs-Dendritic_Cells\|MNPs / lung cells shred on cell class, cell subclass, sample id	ATP8B4 RCSD1 NCKAP5 MEF2C NAV1 IGSF21	9.95e-06	193	113	6	0e6b8e179bfe1c6e93137c76c76a91c7782a4989
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRF1 RASGRF2 ADGRB2 SRCIN1 MEF2C BSN	9.95e-06	193	113	6	be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 COBLL1 ID4 AHNAK PLEKHH2 EPHA7	9.95e-06	193	113	6	ffa1932da2979d7b63dbac32eb5788346a3f5b2a
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DTL SNRK NCKAP5 MEF2C ZFPM2 CTNND2	9.95e-06	193	113	6	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BNC2 MYLK NAV2 MACF1 PLEKHH2 PALLD	9.95e-06	193	113	6	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	BNC2 MYLK ZFPM2 DGKI PLEKHH2 PALLD	9.95e-06	193	113	6	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN MYLK COBLL1 DGKB SMARCA1 PALLD	9.95e-06	193	113	6	0266a4fdf436d83ec1d9392abba8c6ec5166970a
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRF1 RASGRF2 ADGRB2 SRCIN1 MEF2C BSN	9.95e-06	193	113	6	0c652ebe22ce5d2927599dd97ef1920547858395
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGRF1 RASGRF2 ADGRB2 SRCIN1 MEF2C BSN	9.95e-06	193	113	6	8689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK DGKB MEF2C MYOZ1 ZFHX3 PALLD	1.02e-05	194	113	6	5099e6ad7c19e5f8b73449d904aaefd97f1b1959
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK DGKB MEF2C MYOZ1 ZFHX3 PALLD	1.02e-05	194	113	6	71734ef7b34ab33b349595368176fa0e1175d4d0
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN MYLK COBLL1 DGKB ID4 MYOZ1	1.02e-05	194	113	6	fb234d97191c95b7880280c6e4ed5df124ffb0e1
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ATP8B4 PFKFB3 MEF2C CEP170 IGSF21 SMAP2	1.02e-05	194	113	6	663e7e7fe48157e808b4f1a0ea6ad41944e857a2
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DTL SNRK MEF2C ZFPM2 NAV1 CTNND2	1.02e-05	194	113	6	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DTL SNRK MEF2C ZFPM2 NAV1 CTNND2	1.02e-05	194	113	6	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	BNC2 ZFPM2 TC2N NAV2 NAV1 ZFHX3	1.02e-05	194	113	6	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	RASGRF2 ANKRD36C RNF157 TC2N LPIN2 MACF1	1.06e-05	195	113	6	4bdedd924564a260841a9153604026b57487c83d
ToppCell	367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ATP8B4 RB1 NCKAP5 MEF2C NAV2 IGSF21	1.06e-05	195	113	6	4008fa86b5166087a4b20f89ae07e1dfc87c855d
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	BNC2 TC2N NAV2 NAV1 ZFHX3 PLEKHH2	1.06e-05	195	113	6	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 MEF2C CEP170 LPIN2 MACF1 ZFHX3	1.06e-05	195	113	6	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	human_hepatoblastoma-Inflammatory_Monocytes\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	TANC2 BNC2 ATP8B4 RCSD1 PFKFB3 IGSF21	1.06e-05	195	113	6	ba7f85e5307d96ac5ad7c952f8d094db9ca1790c
ToppCell	Fibroblasts-Pericytes\|Fibroblasts / lung cells shred on cell class, cell subclass, sample id	PRUNE2 MYLK ID4 MEF2C MYOZ1 ZFHX3	1.06e-05	195	113	6	c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1
ToppCell	cellseq-Immune-Immune_Myeloid-iMON\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LILRA2 RCSD1 NUP214 PFKFB3 MEF2C SMAP2	1.09e-05	196	113	6	5842d6fa0c066815d7d8c7e59b192bfc72960707
ToppCell	cellseq-Immune-Immune_Myeloid-iMON-iMON\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LILRA2 RCSD1 NUP214 PFKFB3 MEF2C SMAP2	1.09e-05	196	113	6	8608be3c3e7fd776c5f2fae207cd0b801e138349
ToppCell	distal-3-Hematologic-IGSF21+_Dendritic\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ATP8B4 RB1 MEF2C ZFHX3 TGM7 IGSF21	1.12e-05	197	113	6	52e9dc35dd8cc2605fa4894bb16bb5c6086faa76
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	BNC2 RASGRF2 PFKFB3 MEF2C NAV2 ADAMTS18	1.15e-05	198	113	6	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 BNC2 MYLK DGKB RGS3 EPHA7	1.15e-05	198	113	6	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	normal_Lung-Fibroblasts-Smooth_muscle_cells\|Fibroblasts / Location, Cell class and cell subclass	PRUNE2 MYLK ID4 RCSD1 MEF2C MYOZ1	1.18e-05	199	113	6	d65847ceb68a560798df3f73e6f838e7c3e38a1c
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 MYLK ID4 ZFPM2 PALLD EPHA7	1.18e-05	199	113	6	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TANC2 CEP350 NCOR1 ITSN2 LPIN2 BOD1L1	1.18e-05	199	113	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	MYLK ID4 MEF2C MYOZ1 ZFHX3 PALLD	1.18e-05	199	113	6	c8bc05dece8b8a87d4a7a3e8112b924e15217de1
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYLK ID4 MEF2C MYOZ1 ZFHX3 PALLD	1.18e-05	199	113	6	78b245d40c1e169ff2d26907b63d732e34529c5f
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYLK ID4 MEF2C MYOZ1 ZFHX3 PALLD	1.18e-05	199	113	6	8e1e95c3a4b856415af208be6ad977e575bac189
ToppCell	390C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PRUNE2 MYLK ID4 MEF2C MYOZ1 PALLD	1.22e-05	200	113	6	2bc7f462a551292de2501028164573935232f899
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 MYLK ID4 ZFPM2 ZFHX3 PALLD	1.22e-05	200	113	6	f599e4b051ac3dad11ad437e98dc8ea6754cca53
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	TRAF3 EP400 COBLL1 VPS13D AHNAK LPIN2 MKI67 AFF1 MACF1	4.12e-07	191	111	9	4168_DN
Drug	Florfenicol [73231-34-2]; Up 200; 11.2uM; HL60; HT_HG-U133A	PRUNE2 MAP4 COBLL1 POM121L2 MEF2C NAV2 ZFHX3 EPS8L3 PALLD	5.12e-07	196	111	9	3083_UP
Drug	2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A	TRAF3 NSD2 SNRK MED1 ZNF236 MEF2C NCOR1 RABIF	5.21e-06	195	111	8	1163_DN
Drug	Acyclovir [59277-89-3]; Up 200; 17.8uM; PC3; HT_HG-U133A	COL10A1 ATXN7L1 NSD2 ADGRB2 ZNF236 SULT1C2 PIGO EPHA7	5.41e-06	196	111	8	4683_UP
Drug	tamoxifen citrate; Down 200; 1uM; MCF7; HG-U133A	DTL ZNF236 LPIN2 MKI67 AP3M2 AFF1 DLEC1 GREB1	5.62e-06	197	111	8	143_DN
Disease	PR interval	ARID4A DAG1 DGKB NCKAP5 ZFPM2 LPIN2 NAV2 AFF1 MACF1 DLEC1 CTNND2	1.76e-06	495	106	11	EFO_0004462
Disease	Prostatic Neoplasms	RB1 ARID4A SHBG DAG1 NCOR1 FOXP4 ITSN2 SMARCA1 ZFHX3 EPS8L3 GREB1 MGA	2.27e-06	616	106	12	C0033578
Disease	Malignant neoplasm of prostate	RB1 ARID4A SHBG DAG1 NCOR1 FOXP4 ITSN2 SMARCA1 ZFHX3 EPS8L3 GREB1 MGA	2.27e-06	616	106	12	C0376358
Disease	testosterone measurement	KIF18A ZCWPW1 NYAP2 SLC17A3 COBLL1 SHBG DNAH2 DAG1 DGKB ZFPM2 GTF3C2 DGKI AFF1 MACF1 ZFHX3 GREB1	1.27e-05	1275	106	16	EFO_0004908
Disease	cortical surface area measurement	TANC2 BNC2 NYAP2 RCSD1 NCKAP5 MEF2C NCOR1 NAV2 NAV1 ADAMTS18 DGKI AFF1 MACF1 ZFHX3 MOV10 EPHA7	2.44e-05	1345	106	16	EFO_0010736
Disease	forced expiratory volume	BNC2 ATP8B4 ZCWPW1 DGKB ID4 POM121L2 MED1 NCOR1 AHNAK ERCC6L2 AFF1 CTNND2	2.72e-05	789	106	12	EFO_0004314
Disease	Malignant neoplasm of breast	RASGRF2 RB1 NSD2 NUP214 APOC4 NCOR1 FOXP4 ITSN2 MKI67 AFF1 MACF1 BOD1L1 DLEC1 PLEKHA8	3.09e-05	1074	106	14	C0006142
Disease	Alzheimer disease, educational attainment	NYAP2 MAP4 DAG1 MEF2C CEP170 DGKI BSN	3.19e-05	247	106	7	EFO_0011015, MONDO_0004975
Disease	cortical thickness	BNC2 NYAP2 NCKAP5 MEF2C VPS13D UBN1 NAV2 NAV1 ADAMTS18 DGKI AFF1 MACF1 DLEC1 EPHA7	4.54e-05	1113	106	14	EFO_0004840
Disease	SPARC measurement	VTN ZFPM2	7.63e-05	4	106	2	EFO_0020748
Disease	body fat percentage, high density lipoprotein cholesterol measurement	NYAP2 COBLL1 SHBG	9.78e-05	25	106	3	EFO_0004612, EFO_0007800
Disease	apolipoprotein B measurement	BNC2 VTN COBLL1 APOC4 GTF3C2 AFF1 ZFHX3 EPS8L3 PLEKHH2 SPTY2D1	1.41e-04	663	106	10	EFO_0004615
Disease	free cholesterol to total lipids in large LDL percentage	NYAP2 COBLL1 AFF1 MACF1	1.49e-04	74	106	4	EFO_0022280
Disease	intellectual disability (implicated_via_orthology)	RB1 MEF2C ITSN2 BOD1L1	1.57e-04	75	106	4	DOID:1059 (implicated_via_orthology)
Disease	body fat percentage, fasting blood insulin measurement	NYAP2 COBLL1	1.90e-04	6	106	2	EFO_0004466, EFO_0007800
Disease	inactive peptidyl-prolyl cis-trans isomerase FKBP6 measurement	VTN APOC4	1.90e-04	6	106	2	EFO_0801694
Disease	apolipoprotein A 1 measurement	TRAF3 NYAP2 VTN COBLL1 APOC4 ZFPM2 LPIN2 AFF1 MACF1 DLEC1 MGA	2.41e-04	848	106	11	EFO_0004614
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	NYAP2 VTN COBLL1 APOC4 AFF1 MACF1	2.52e-04	243	106	6	EFO_0004612, EFO_0020944
Disease	testican-3 measurement	VTN ZFPM2	2.65e-04	7	106	2	EFO_0802124
Disease	MAP kinase-activated protein kinase 5 measurement	VTN APOC4	2.65e-04	7	106	2	EFO_0020553
Disease	attention deficit hyperactivity disorder	BNC2 NYAP2 NCKAP5 MEF2C NAV2 ZFHX3 DLEC1	2.97e-04	354	106	7	EFO_0003888
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	BNC2 TRAF3 NYAP2 COBLL1 UBN1 MACF1 ZFHX3	3.51e-04	364	106	7	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	cytidine measurement	VTN SLC17A3	3.53e-04	8	106	2	EFO_0800645
Disease	triacylglycerol 51:2 measurement	NYAP2 GTF3C2	3.53e-04	8	106	2	EFO_0021483
Disease	platelet component distribution width	PRUNE2 ZCWPW1 NYAP2 COBLL1 MEF2C ZFPM2 MAVS MACF1 DLEC1 SMAP2	3.97e-04	755	106	10	EFO_0007984
Disease	valine measurement	NYAP2 COBLL1 AFF1	4.04e-04	40	106	3	EFO_0009792
Disease	small nuclear ribonucleoprotein F measurement	VTN APOC4	4.53e-04	9	106	2	EFO_0008288
Disease	waist-hip ratio	PRUNE2 TRAF3 NYAP2 ARID4A ATXN7L1 COBLL1 SHBG DAG1 DGKB RNF157 UBN1 AHNAK DLEC1	4.56e-04	1226	106	13	EFO_0004343
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	NYAP2 VTN COBLL1 APOC4 AFF1 MACF1	4.95e-04	276	106	6	EFO_0004612, EFO_0020943
Disease	Liver carcinoma	KIF18A RB1 DTL MED1 MECP2 RNF157 MKI67 EPS8L3	4.98e-04	507	106	8	C2239176
Disease	body surface area	BNC2 TRAF3 DTL SPATA31C1 UBN1 ITSN2 MACF1 ZFHX3 DLEC1	5.27e-04	643	106	9	EFO_0022196
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	NYAP2 COBLL1 AFF1 MACF1	5.29e-04	103	106	4	EFO_0008595, EFO_0020944
Disease	sexual dimorphism measurement	NYAP2 RASGRF1 COBLL1 SHBG ID4 POM121L2 SPATA31C1 UBN1 MACF1 ZFHX3 BSN MGA	6.25e-04	1106	106	12	EFO_0021796
Disease	diastolic blood pressure, systolic blood pressure	BNC2 TRAF3 ATP8B4 DNAH2 CEP350 NAV1 AFF1 ZFHX3 DLEC1	7.06e-04	670	106	9	EFO_0006335, EFO_0006336
Disease	L2 Acute Lymphoblastic Leukemia	RB1 NSD2 NUP214	7.81e-04	50	106	3	C0023453
Disease	cholesteryl esters to total lipids in IDL percentage	NYAP2 COBLL1 MACF1	7.81e-04	50	106	3	EFO_0022247
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	NYAP2 COBLL1 APOC4 AFF1 MACF1	7.92e-04	200	106	5	EFO_0004611, EFO_0020945
Disease	brain disease (is_implicated_in)	TRAF3 NUP214	8.24e-04	12	106	2	DOID:936 (is_implicated_in)
Disease	disks large homolog 3 measurement	MEF2C ZFPM2	8.24e-04	12	106	2	EFO_0802472
Disease	tumor necrosis factor receptor superfamily member EDAR measurement	MEF2C ZFPM2	8.24e-04	12	106	2	EFO_0008310
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	NYAP2 COBLL1 AFF1	8.28e-04	51	106	3	EFO_0022302
Disease	Childhood Acute Lymphoblastic Leukemia	RB1 NSD2 NUP214	8.76e-04	52	106	3	C0023452
Disease	free cholesterol to total lipids in small LDL percentage	NYAP2 COBLL1 AFF1	9.26e-04	53	106	3	EFO_0022286
Disease	age at first birth measurement	KIF18A BNC2 TRAF3 ID4	9.39e-04	120	106	4	EFO_0009101
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	NYAP2 COBLL1 AFF1 MACF1	9.68e-04	121	106	4	EFO_0008595, EFO_0020943
Disease	total lipids in medium VLDL	COBLL1 APOC4 AFF1	9.78e-04	54	106	3	EFO_0022153
Disease	triglycerides in medium HDL measurement	COBLL1 APOC4 AFF1	9.78e-04	54	106	3	EFO_0022321
Disease	triglycerides in medium VLDL measurement	NYAP2 COBLL1 AFF1	1.03e-03	55	106	3	EFO_0022155
Disease	cholesterol to total lipids in large HDL percentage	NYAP2 COBLL1 AFF1	1.03e-03	55	106	3	EFO_0022234
Disease	free cholesterol to total lipids in very large HDL percentage	NYAP2 COBLL1 APOC4	1.03e-03	55	106	3	EFO_0022288
Disease	vascular endothelial growth factor measurement	DNAH2 MEF2C ZFPM2	1.09e-03	56	106	3	EFO_0004762
Disease	triglycerides in large VLDL measurement	NYAP2 COBLL1 AFF1	1.09e-03	56	106	3	EFO_0022178
Disease	triglycerides in LDL measurement	NYAP2 COBLL1 AFF1	1.09e-03	56	106	3	EFO_0022320
Disease	triglycerides in very large VLDL measurement	NYAP2 COBLL1 AFF1	1.09e-03	56	106	3	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	NYAP2 COBLL1 AFF1	1.09e-03	56	106	3	EFO_0022333
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	NYAP2 COBLL1 AFF1	1.09e-03	56	106	3	EFO_0022316
Disease	cholesterol to total lipids in large LDL percentage	NYAP2 COBLL1 AFF1	1.09e-03	56	106	3	EFO_0022235
Disease	cholesteryl esters to total lipids in medium HDL percentage	NYAP2 COBLL1 AFF1	1.09e-03	56	106	3	EFO_0022251
Disease	breast carcinoma	TRAF3 NYAP2 SLC17A3 MAP4 POM121L2 ZFPM2 AHRR GREB1 SLC45A1 IGSF21 SPTY2D1	1.10e-03	1019	106	11	EFO_0000305
Disease	triacylglycerol 46:2 measurement	GTF3C2 ANKRD34C	1.13e-03	14	106	2	EFO_0010402
Disease	smoking cessation	NYAP2 ATXN7L1 SHBG ZFHX3 BSN IGSF21	1.16e-03	325	106	6	EFO_0004319
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	NYAP2 COBLL1 AFF1 MACF1	1.16e-03	127	106	4	EFO_0008595, EFO_0020947
Disease	irritable bowel syndrome symptom measurement	TRIM67 NAV2 CTNND2	1.20e-03	58	106	3	EFO_0021536
Disease	free cholesterol in medium HDL measurement	NYAP2 VTN APOC4	1.20e-03	58	106	3	EFO_0022267
Disease	triglycerides in VLDL measurement	NYAP2 COBLL1 AFF1	1.27e-03	59	106	3	EFO_0022326
Disease	triglycerides to total lipids in small LDL percentage	NYAP2 COBLL1 AFF1	1.27e-03	59	106	3	EFO_0022337
Disease	cholesteryl esters to total lipids in large HDL percentage	NYAP2 COBLL1 AFF1	1.27e-03	59	106	3	EFO_0022248
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	NYAP2 COBLL1 AFF1	1.27e-03	59	106	3	EFO_0022260
Disease	triglycerides to total lipids in large HDL percentage	NYAP2 COBLL1 AFF1	1.33e-03	60	106	3	EFO_0022330
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	NYAP2 COBLL1 AFF1	1.33e-03	60	106	3	EFO_0021898
Disease	total lipids in VLDL measurement	NYAP2 COBLL1 AFF1	1.33e-03	60	106	3	EFO_0022314
Disease	cholesterol to total lipids in IDL percentage	NYAP2 COBLL1 MACF1	1.33e-03	60	106	3	EFO_0022233
Disease	cholesterol to total lipids in medium HDL percentage	NYAP2 COBLL1 AFF1	1.33e-03	60	106	3	EFO_0022237
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	NYAP2 COBLL1 APOC4 AFF1 MACF1	1.34e-03	225	106	5	EFO_0008317, EFO_0020947
Disease	venous thromboembolism	ATXN7L1 DGKB ZFPM2 TC2N NAV2 DLEC1 IGSF21	1.38e-03	460	106	7	EFO_0004286
Disease	phospholipids:total lipids ratio	NYAP2 VTN COBLL1 AFF1 MACF1	1.39e-03	227	106	5	EFO_0020946
Disease	triglycerides in small VLDL measurement	NYAP2 COBLL1 AFF1	1.39e-03	61	106	3	EFO_0022145
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	RB1 NSD2 NUP214	1.39e-03	61	106	3	C1961102
Disease	free cholesterol in very large VLDL measurement	NYAP2 COBLL1 AFF1	1.39e-03	61	106	3	EFO_0022274
Disease	free cholesterol in HDL measurement	NYAP2 COBLL1 APOC4	1.39e-03	61	106	3	EFO_0022264
Disease	phospholipids in HDL measurement	NYAP2 VTN APOC4	1.39e-03	61	106	3	EFO_0022293
Disease	triglycerides in small HDL measurement	NYAP2 COBLL1 AFF1	1.46e-03	62	106	3	EFO_0022158
Disease	phospholipids in large VLDL measurement	NYAP2 COBLL1 AFF1	1.46e-03	62	106	3	EFO_0022169
Disease	triglycerides in medium LDL measurement	NYAP2 COBLL1 AFF1	1.46e-03	62	106	3	EFO_0022322
Disease	triglycerides to total lipids in very large HDL percentage	NYAP2 COBLL1 AFF1	1.46e-03	62	106	3	EFO_0022339
Disease	total lipids in chylomicrons and extremely large VLDL measurement	NYAP2 COBLL1 AFF1	1.46e-03	62	106	3	EFO_0022306
Disease	total lipids in very large VLDL measurement	NYAP2 COBLL1 AFF1	1.46e-03	62	106	3	EFO_0022313
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	NYAP2 COBLL1 AFF1	1.46e-03	62	106	3	EFO_0022263
Disease	phospholipids in very large VLDL measurement	NYAP2 COBLL1 AFF1	1.46e-03	62	106	3	EFO_0022299
Disease	smoking behavior	NYAP2 RASGRF2 ADGRB2 NAV2 ZFHX3 EPHA7	1.48e-03	341	106	6	EFO_0004318
Disease	cochlin measurement	MEF2C ZFPM2	1.48e-03	16	106	2	EFO_0801481
Disease	leptin measurement, type 2 diabetes mellitus	NYAP2 COBLL1	1.48e-03	16	106	2	EFO_0005000, MONDO_0005148
Disease	body mass index, type 2 diabetes mellitus	NYAP2 COBLL1	1.48e-03	16	106	2	EFO_0004340, MONDO_0005148
Disease	total lipids in HDL measurement	NYAP2 VTN APOC4	1.53e-03	63	106	3	EFO_0022307
Disease	free cholesterol to total lipids in medium LDL percentage	NYAP2 COBLL1 AFF1	1.53e-03	63	106	3	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	NYAP2 COBLL1 AFF1	1.53e-03	63	106	3	EFO_0022292
Disease	triglycerides in small LDL measurement	NYAP2 COBLL1 AFF1	1.67e-03	65	106	3	EFO_0022323
Disease	cholesterol in large VLDL measurement	NYAP2 COBLL1 AFF1	1.67e-03	65	106	3	EFO_0021902
Disease	cholesterol in very large VLDL measurement	NYAP2 COBLL1 AFF1	1.67e-03	65	106	3	EFO_0022230
Disease	Muscle hypotonia	NSD2 MECP2	1.68e-03	17	106	2	C0026827

Protein segments in the cluster

Peptide	Gene	Start	Entry
KKAPSGAMLPPRLSL	AHRR	256	A9YTQ3
TFKSMTLGSLPPKPR	ADGRB2	1546	O60241
AMLPSPPKQKSSPVN	CEP170	1511	Q5SW79
TAGKRSPPIKPLLGM	EP400	2471	Q96L91
RGRPPLKSTLSSNMP	ARID4A	666	P29374
LKSMVPVAPSSPKRV	ANKRD34C	491	P0C6C1
RSPSGKMKGLPSVTP	AMBN	366	Q9NP70
KSNLALTSPGRPPMG	BNC2	526	Q6ZN30
LPGASPKSPGLKAMV	RCSD1	101	Q6JBY9
GPSLKMPSLEISAPK	AHNAK	4901	Q09666
LITSGKNMRAKNPPP	ATP8B4	1141	Q8TF62
MAAKRKAENPSPRSP	DTL	666	Q9NZJ0
AQEGTLSPPPKLKMS	APOC4	31	P55056
SPLKPAPKMTRDTGT	COBLL1	821	Q53SF7
KPPMRSLSQSQGDPL	CTNND2	431	Q9UQB3
MSKSVPPSPEKILNG	ATXN7L1	246	Q9ULK2
PKVMNGTPPATKRPA	ADAMTS18	861	Q8TE60
GSELPANSPLKIPKM	MSANTD2	6	Q6P1R3
MPPKTPRKTAATAAA	RB1	1	P06400
MPSPSTLKKELGRNG	RGS3	976	P49796
PRCKGMPLSSFLLKP	ITSN2	1336	Q9NZM3
SKKPSLSVQPGPMVA	LILRA2	221	Q8N149
AAMRRKDSPPPGKVS	ANKRD36C	566	Q5JPF3
INPQKLPSLKGTMSL	AP3M2	346	P53677
GSSKQPLPIKAMLRS	SLC17A3	201	O00476
MKSRRPKSSLPPVLG	MYLK	1201	Q15746
PSKLPINSTRAGMVP	MAVS	346	Q7Z434
MSLASGLVPAAPPKR	MAP4	741	P27816
GLPKAASLLPSPSVM	GREB1	1276	Q4ZG55
MPKLAPLGLKVANPS	MGA	2986	Q8IWI9
LMPSPLKGQHTLKSP	KIF18A	671	Q8NI77
PPLKRSASNKVPAMQ	ZFPM2	716	Q8WW38
PSMRKKPALSDGSNP	RABIF	46	P47224
RPMKTLQRSLSDPKP	BSN	2841	Q9UPA5
KGSRPKNMTPYRSPP	DAG1	876	Q14118
KGPNPLMRRNSVTPL	PFKFB3	451	Q16875
SRPSSPKPAQPALKM	EPS8L3	441	Q8TE67
GSPPGRKKTTVSMPR	NSD2	436	O96028
SRRGLNKPSKIPTMS	MACF1	3486	O94854
SMVQKSPRITPPAAK	NUP214	661	P35658
RVLIPPGSKNTMPSV	MEF2C	256	Q06413
RRPPKMTGSPTLVKN	FOXP4	546	Q8IVH2
LTPSAGKAMLTPKPA	MKI67	1166	P46013
PPGSPQLAMLKSSKM	PLEKHA8	186	Q96JA3
SMGRSLTPLSLKRPP	NYAP2	441	Q9P242
MKAVSPVRPSGRKAP	ID4	1	P47928
DKMIRNPNSLKTPLG	EPHA7	891	Q15375
SELKNQMAKPPSLAP	GOLGA6B	276	A6NDN3
ANPLSLQPEGKPTMK	PLEKHH2	801	Q8IVE3
PVSKRKPAMSPLLTR	PALLD	116	Q8WX93
SLQRPKKSGDMTLIP	BOD1L1	1101	Q8NFC6
LPTTSLQPKAMLGPA	C6orf132	626	Q5T0Z8
TPKGLSPAMSPALQR	ESS2	386	Q96DF8
KQSPPMASSPIQPRK	FBF1	326	Q8TES7
PKGPKIVMTPSRARV	IGSF21	341	Q96ID5
RMKGSLPSLSPFPQS	CPLANE1	1226	Q9H799
GRPFVIKPISSPLMK	DGKI	361	O75912
SPEKSRKMLPTPIGT	CRAMP1	1171	Q96RY5
TLKRLKGLTPSSMPG	REXO1L1P	346	Q8IX06
LPLKNTKNGLSPGMR	BCE1	26	O60756
MRSSKSKEVPLPNPR	CEP350	1	Q5VT06
PMVKSKPALLSGGLR	DGKB	96	Q9Y6T7
SPTQLPKKVLSGPME	ERCC6L2	1466	Q5T890
SMKPARASGPKARPS	GPRIN2	71	O60269
SLSKKTSLPNMPPAL	DLEC1	1141	Q9Y238
TTEPPKGLKANMTRL	DNAH2	3946	Q9P225
SEKRAAMKSPSLPLP	SLC45A1	331	Q9Y2W3
GKPSSLMNPSLSKPN	MED1	1176	Q15648
PSPAVPKLSMAKCRR	LRCH2	696	Q5VUJ6
SPGKLLVKMPFQTSP	MECP2	216	P51608
PRGVAMLTSDPPKLN	GRIN3B	726	O60391
SPPALPMSLSAKGQL	NAV1	981	Q8NEY1
LPKPFSNPKSMNRTV	FNDC8	31	Q8TC99
RAMRKKLGPLSPTSF	RNF157	326	Q96PX1
LTSNKQKPVMGPPLR	TDRD3	231	Q9H7E2
LKNTGKRIPPTPMNS	PRUNE2	601	Q8WUY3
PSAQKSPTSPLNMKL	SMARCA1	111	P28370
SPTSPLNMKLGRPRI	SMARCA1	116	P28370
RTNKLPGSPGLSKSM	TC2N	161	Q8N9U0
MRPLQSRLPKPASSG	NCKAP5	1801	O14513
KPMTPFKRTRITGNP	MOV10	251	Q9HCE1
RPLRMAASSKKPPIS	RASGRF2	271	O14827
LITGPSKLSRGMPPL	NCOR1	1406	O75376
TMPRTKPSAPAGALK	NAV2	1071	Q8IVL1
SKMKALALPPLGLAP	SHBG	321	P04278
SQLPGRPKSPLSKMA	TANC2	1571	Q9HCD6
PPMASLRKQVLTKPS	SPATA31C1	716	P0DKV0
SRPGPMVTPHNKAKS	SPTY2D1	351	Q68D10
FLRPLRMAASSKKPP	RASGRF1	266	Q13972
PPKLSRLKMNIASPG	SNRK	506	Q9NRH2
MKKSQNSPLGPLPSD	POM121L2	81	Q96KW2
PPSLPSKSVAMQQKP	AFF1	276	P51825
QMPTGIKGPLPNTKT	COL10A1	26	Q03692
TPSLKSPNGVRVLPM	TRIM67	116	Q6ZTA4
KMDSPGALQTNPPLK	TRAF3	6	Q13114
MKRSLGRKSTAPPAP	ZCWPW1	511	Q9H0M4
VPPMKVVTPGASRLK	SRCIN1	1096	Q9C0H9
AASKSMPISIPKAPR	SARG	436	Q9BW04
MPISIPKAPRANSAL	SARG	441	Q9BW04
QLPRKSSPKSTAPVM	SMAP2	171	Q8WU79
PSGVEKAKAMPSPRI	SULT1C2	91	O00338
PPKVSLMPATLARAA	TAPBP	291	O15533
TSRPVPSSAGKKMPV	UBN1	946	Q9NPG3
PDPKKARKPMTRSSS	ZNF236	1276	Q9UL36
PPKLLTMPRLGTSAT	PIGO	596	Q8TEQ8
QSNPLSTPMPKKRGR	GTF3C2	131	Q8WUA4
PPPISGKNLRQMSKD	TBC1D20	81	Q96BZ9
KASRKMLGPQRASLP	TGM7	461	Q96PF1
ISGMAPRPSLAKKQR	VTN	356	P04004
SSGNPMAKPESRRLK	THAP4	131	Q8WY91
SKGPMILLQATKDPP	ZP4	481	Q12836
MTSRDQPRPKGPPKS	TLE6	1	Q9H808
NTALTSPKPNLMGLP	ZFHX3	3141	Q15911
KNLMVSRGAPKPSSL	VPS13D	1686	Q5THJ4
PALSLTQMAKPKPQT	KIAA1958	226	Q8N8K9
KPKPRALGTQMSDPT	LPIN2	326	Q92539
MPLSGTPAPNKKRKS	MYOZ1	1	Q9NP98